Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl- channels
- PMID: 8744307
- PMCID: PMC1225249
- DOI: 10.1016/S0006-3495(96)79839-9
Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl- channels
Abstract
Cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial Cl- channel that is regulated by protein kinase A and cytosolic nucleotides. Previously, Sheppard and Welsh reported that the sulfonylureas glibenclamide and tolbutamide reduced CFTR whole cell currents. The aim of this study was to quantify the effects of tolbutamide on CFTR gating in excised membrane patches containing multiple channels. We chose tolbutamide because weak (i.e., fast-type) open channel blockers introduce brief events into multichannel recordings that can be readily quantified by current fluctuation analysis. Inspection of current records revealed that the addition of tolbutamide reduced the apparent single-channel current amplitude and increased the open-channel noise, as expected for a fast-type open channel blocker. The apparent decrease in unitary current amplitude provides a measure of open probability within a burst (P0 Burst), and the resulting concentration-response relationship was described by a simple Michaelis-Menten inhibition function. The concentration of tolbutamide causing a 50% reduction of Po Burst (540 +/- 20 microM) was similar to the concentration producing a 50% inhibition of short-circuit current across T84 colonic epithelial cell monolayers (400 +/- 20 microM). Changes in CFTR gating were then quantified by analyzing current fluctuations. Tolbutamide caused a high-frequency Lorentzian (corner frequency, fc > 300 Hz) to appear in the power density spectrum. The fc of this Lorentzian component increased as a linear function of tolbutamide concentration, as expected for a pseudo-first-order open-blocked mechanism and yielded estimates of the on rate (koff = 2.8 +/- 0.3 microM-1 s-1), the off rate (kon = 1210 +/- 225 s-1), and the dissociation constant (KD = 430 +/- 80 microM). Based on these observations, we propose that there is a bimolecular interaction between tolbutamide and CFTR, causing open channel blockade.
Similar articles
-
Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.Br J Pharmacol. 1999 Sep;128(1):108-18. doi: 10.1038/sj.bjp.0702748. Br J Pharmacol. 1999. PMID: 10498841 Free PMC article.
-
ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism.J Gen Physiol. 1994 Jul;104(1):123-46. doi: 10.1085/jgp.104.1.123. J Gen Physiol. 1994. PMID: 7525859 Free PMC article.
-
Glibenclamide blockade of CFTR chloride channels.Am J Physiol. 1996 Aug;271(2 Pt 1):L192-200. doi: 10.1152/ajplung.1996.271.2.L192. Am J Physiol. 1996. PMID: 8770056
-
Endogenous chloride channels of insect sf9 cells. Evidence for coordinated activity of small elementary channel units.J Gen Physiol. 1996 Jun;107(6):695-714. doi: 10.1085/jgp.107.6.695. J Gen Physiol. 1996. PMID: 8783071 Free PMC article. Review.
-
Pharmacology of CFTR chloride channel activity.Physiol Rev. 1999 Jan;79(1 Suppl):S109-44. doi: 10.1152/physrev.1999.79.1.S109. Physiol Rev. 1999. PMID: 9922378 Review.
Cited by
-
Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.J Bioenerg Biomembr. 1997 Oct;29(5):429-42. doi: 10.1023/a:1022478822214. J Bioenerg Biomembr. 1997. PMID: 9511928 Review.
-
Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line.J Physiol. 1997 Sep 1;503 ( Pt 2)(Pt 2):333-46. doi: 10.1111/j.1469-7793.1997.333bh.x. J Physiol. 1997. PMID: 9306276 Free PMC article.
-
Probing the structural and functional domains of the CFTR chloride channel.J Bioenerg Biomembr. 1997 Oct;29(5):453-63. doi: 10.1023/a:1022482923122. J Bioenerg Biomembr. 1997. PMID: 9511930 Review.
-
Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.Br J Pharmacol. 1999 Sep;128(1):108-18. doi: 10.1038/sj.bjp.0702748. Br J Pharmacol. 1999. PMID: 10498841 Free PMC article.
-
Murine and human CFTR exhibit different sensitivities to CFTR potentiators.Am J Physiol Lung Cell Mol Physiol. 2015 Oct 1;309(7):L687-99. doi: 10.1152/ajplung.00181.2015. Epub 2015 Jul 24. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 26209275 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical